KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 150 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $103,693,000 | -9.1% | 30,498 | +0.5% | 0.00% | – |
| Q2 2018 | $114,105,000 | +24.7% | 30,347 | +35.6% | 0.00% | – |
| Q1 2018 | $91,506,000 | -8.9% | 22,373 | +3.6% | 0.00% | – |
| Q4 2017 | $100,445,000 | +47.3% | 21,601 | +124.9% | 0.00% | – |
| Q3 2017 | $68,181,000 | -7.1% | 9,603 | -5.4% | 0.00% | – |
| Q2 2017 | $73,399,000 | +627.4% | 10,152 | +519.8% | 0.00% | – |
| Q1 2017 | $10,090,000 | -69.5% | 1,638 | -70.9% | 0.00% | – |
| Q4 2016 | $33,033,000 | -7.5% | 5,637 | -16.2% | 0.00% | – |
| Q3 2016 | $35,715,000 | +77.9% | 6,726 | +121.8% | 0.00% | – |
| Q2 2016 | $20,078,000 | -83.2% | 3,033 | -87.2% | 0.00% | – |
| Q4 2015 | $119,504,000 | +58.5% | 23,664 | +10.5% | 0.00% | – |
| Q3 2015 | $75,398,000 | -12.3% | 21,420 | +148.5% | 0.00% | – |
| Q2 2015 | $86,008,000 | +238.8% | 8,618 | +332.2% | 0.00% | – |
| Q1 2015 | $25,384,000 | -69.4% | 1,994 | -67.0% | 0.00% | – |
| Q3 2014 | $83,064,000 | +2009.8% | 6,041 | +2259.8% | 0.00% | – |
| Q2 2014 | $3,937,000 | +122.2% | 256 | +113.3% | 0.00% | – |
| Q1 2014 | $1,772,000 | -87.1% | 120 | -88.7% | 0.00% | – |
| Q4 2013 | $13,727,000 | -94.0% | 1,060 | -95.3% | 0.00% | – |
| Q3 2013 | $227,318,000 | +5.0% | 22,529 | -22.3% | 0.00% | – |
| Q2 2013 | $216,496,000 | – | 28,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |